Boston Trust Walden Corp Horizon Therapeutics Public LTD CO Transaction History

Boston Trust Walden Corp

  • $14.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
SELL
$79.4 - $116.36 $185,875 - $272,398
-2,341 Closed
0 $0
Q4 2021

Jan 21, 2022
SELL
$98.56 - $119.91 $5,815 - $7,074
-59 Reduced 2.46%
2,341 $252,000
Q3 2021

Oct 25, 2021
BUY
$91.91 - $110.37 $220,584 - $264,888
2,400 New
2,400 $263,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email